After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Regeneron Pharmaceuticals, Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Regeneron Pharmaceuticals, Inc is $86.62B. A total of 0.81 million shares were traded on the day, compared to an average of 758.42K shares.
In the most recent transaction, McCourt Marion sold 1,000 shares of REGN for 844.61 per share on Nov 01 ’24. After the transaction, the EVP Commercial now owns 12,931 company shares. In a previous transaction on Nov 01 ’24, MARION E MCCOURT bought 1,000 shares at 844.61 per share.
Among the insiders who sold shares, RYAN ARTHUR F disposed of 100 shares on Oct 01 ’24 at a per-share price of $1048.78. This resulted in the Director holding 17,582 shares of REGN after the transaction. In another insider transaction, McCourt Marion sold 1,000 shares at $1054.06 per share on Oct 01 ’24. Company shares held by the EVP Commercial now total 12,931.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, REGN has a high of $1211.20 and a low of $735.95.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. REGN’s latest balance sheet shows that the firm has $5.69B in Cash & Short Term Investments as of fiscal 2021. There were $2.70B in debt and $3.93B in liabilities at the time. Its Book Value Per Share was $266.36, while its Total Shareholder’s Equity was $18.77B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for REGN is Buy with a score of 4.41.
